Pilot Studies for 2006/2007
Pharmacogenetics and molecular adaptations in nicotine addiction
Identification of chemopreventive agents against lung cancer induced by smoking
Principal investigator: Chengguo Xing, PhDProteomic analysis of bronchoalveolar lavage: smokers vs. non-smokers.
Principal investigator: Christine Wendt, MDOxygen transport rate: a potential biomarker for cardiovascular disease
Principal investigator: Henry Buchwald, MD, PhDRole of the translational repressor 4E-BP in lung epithelial carcinogenesis induced by tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. (NNK)
Principal investigator: Peter Bitterman, MDSmokeless tobacco vs. medicinal nicotine: Pharmacokinetics and pharmacodynamics in humans.
Principal investigator: Irene Baumgart, MDCharacterization of negative affect during nicotine withdrawal in rats. (Career development award)
Principal investigator: Jonathan Gewirtz, PhDImplications of the TDRL computational model of addiction on smoking. (Career development award)
Principal investigator: A. David Redish, PhDPilot Studies for 2000-2004
Pulmonary-specific retention of an NNK metabolite
Principal investigator: Cheryl Zimmerman, Ph.D.Separate effects of tobacco extract and nicotine on fracture repair in rats
Principal investigator: Joan Bechtold, Ph.D.Nicotine CNS distributional kinetics using microdialysis sampling
Principal investigator: William Elmquist, Pharm.D., Ph.D.Understanding attitudes toward tobacco harm reduction: social psychological and policy implications
Principal investigator: Gene Borgida, PhDEffects of opiate blockade on stress hormones in dependent smokers
Principal investigator: Mustafa al’Absi, Ph.D.Investigation of the effects of nornicotine in animal models of nicotine dependence
Principal investigator: Mark LeSage, Ph.D.Impact of smoking on the integrity of mucosal defense against the pneumococcus
Principal investigator: Edward Janoff, MDIdentification of target compounds for chemoprevention of lung cancer in smokers
Principal investigator: Natalia Tretyakova, PhDRacial disparities in the risk of adverse birth outcomes
Principal investigator: Julie Ross, PhD, MPHA double-blind study of bupropion HCl and placebo in the treatment of smoking in schizophrenia
Principal investigator: S.H. Fatemi, MDVaccine effects on nicotine distribution to the fetus
Principal investigator: Paul Pentel, MDPreferences and practices among renters regarding smoking restrictions in apartment buildings
Principal investigator: Deborah Hennrikus, PhDRacial differences in nicotine metabolism using transdermal patches
Principal investigator: Jesse Mason